Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea

Jong Hwa Yum, Sung Hak Choi, DongEun Yong, Yunsop Chong, Weon Bin Im, Dong Kwon Rhee, Kyungwon Lee

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Resistance of Gram-positive pathogens to first-line antimicrobial agents has been increasing in many parts of the world. We compared the in vitro activities of torezolid with those of other antimicrobial agents, including linezolid, against clinical isolates of major aerobic and anaerobic bacteria. Torezolid had an MIC90 of ≤0.5 μg/ml for the Gram-positive bacterial isolates tested and was more potent than either linezolid or vancomycin.

Original languageEnglish
Pages (from-to)5381-5386
Number of pages6
JournalAntimicrobial agents and chemotherapy
Volume54
Issue number12
DOIs
Publication statusPublished - 2010 Dec 1

Fingerprint

Linezolid
Aerobic Bacteria
Republic of Korea
Anaerobic Bacteria
Anti-Infective Agents
Vancomycin
In Vitro Techniques
DA 7157
torezolid

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

@article{5802b378cd764118ab87ec6cbbe98bce,
title = "Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea",
abstract = "Resistance of Gram-positive pathogens to first-line antimicrobial agents has been increasing in many parts of the world. We compared the in vitro activities of torezolid with those of other antimicrobial agents, including linezolid, against clinical isolates of major aerobic and anaerobic bacteria. Torezolid had an MIC90 of ≤0.5 μg/ml for the Gram-positive bacterial isolates tested and was more potent than either linezolid or vancomycin.",
author = "Yum, {Jong Hwa} and Choi, {Sung Hak} and DongEun Yong and Yunsop Chong and Im, {Weon Bin} and Rhee, {Dong Kwon} and Kyungwon Lee",
year = "2010",
month = "12",
day = "1",
doi = "10.1128/AAC.00728-10",
language = "English",
volume = "54",
pages = "5381--5386",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "12",

}

Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea. / Yum, Jong Hwa; Choi, Sung Hak; Yong, DongEun; Chong, Yunsop; Im, Weon Bin; Rhee, Dong Kwon; Lee, Kyungwon.

In: Antimicrobial agents and chemotherapy, Vol. 54, No. 12, 01.12.2010, p. 5381-5386.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea

AU - Yum, Jong Hwa

AU - Choi, Sung Hak

AU - Yong, DongEun

AU - Chong, Yunsop

AU - Im, Weon Bin

AU - Rhee, Dong Kwon

AU - Lee, Kyungwon

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Resistance of Gram-positive pathogens to first-line antimicrobial agents has been increasing in many parts of the world. We compared the in vitro activities of torezolid with those of other antimicrobial agents, including linezolid, against clinical isolates of major aerobic and anaerobic bacteria. Torezolid had an MIC90 of ≤0.5 μg/ml for the Gram-positive bacterial isolates tested and was more potent than either linezolid or vancomycin.

AB - Resistance of Gram-positive pathogens to first-line antimicrobial agents has been increasing in many parts of the world. We compared the in vitro activities of torezolid with those of other antimicrobial agents, including linezolid, against clinical isolates of major aerobic and anaerobic bacteria. Torezolid had an MIC90 of ≤0.5 μg/ml for the Gram-positive bacterial isolates tested and was more potent than either linezolid or vancomycin.

UR - http://www.scopus.com/inward/record.url?scp=78649681818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649681818&partnerID=8YFLogxK

U2 - 10.1128/AAC.00728-10

DO - 10.1128/AAC.00728-10

M3 - Article

VL - 54

SP - 5381

EP - 5386

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 12

ER -